Effectiveness and Efficiency of Two Models of Delivering Care to a Chronic Wound Population

NCT00656383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 401

Last updated 2015-11-20

No results posted yet for this study

Summary

Individuals referred to home care for leg ulcer management were randomized to nurse home visits (usual care) or nurse-run community clinics (intervention). The primary outcome will be the time to healing rates at three months. Secondary outcomes are: time to healing of all ulcers within the 12 month follow-up period, time to first recurrence of a healed ulcer, the number of weeks patients were free from ulcers, function, pain, and health related quality of life, client and provider satisfaction. We hypothesize that nurse-run neighborhood clinics result in better healing rates, more cost-effective care, and improved client and provider satisfaction than the home visiting model.

Conditions

  • Varicose Ulcer

Interventions

OTHER

Clients randomized to nurse-led clinic

Clients receive leg ulcer care in a nurse-led clinic; both groups are treated by the same health care providers using the same protocol

OTHER

Clients receive leg ulcer care in their homes

Clients receive leg ulcer care in at home; both groups are treated by the same health care providers using the same protocol

Sponsors & Collaborators

  • The Ottawa Hospital

    collaborator OTHER
  • University of Ottawa

    collaborator OTHER
  • Queen's University

    lead OTHER

Principal Investigators

  • Margaret B Harrison, RN, PhD · The Ottawa Hospital

  • Ian D Graham, PhD · Clinical Epidemiology Unit, Ottawa Hospital-Civic Campus

  • Philip S Wells, PhD · The Ottawa Hospital

  • Susan VanDeVelde, PhD · Victorian Order of Nurses, Ottawa-Carleton Branch

  • Judith L Threinen, BSR, MHA · Ottawa-Carleton Community Care Access Centre

  • Donna I Nicholson, Dip O&A · Ottawa Carleton Community Care Access Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2004-03-31
Completion
2005-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00656383 on ClinicalTrials.gov